During the Hannover Messe trade fair, industry leaders from Merz and Siemens urged the European Union to relax its regulatory framework concerning industrial artificial intelligence, aiming to foster innovation and efficiency within the sector.

AIM Centre is extending its reach beyond its Sligo headquarters by establishing a new base in Galway, aiming to tap into the growing medtech and life sciences clusters in the west of Ireland.

New York-based startup Coral has developed AI technology capable of reading handwritten fax forms, handling prior authorizations, and completing patient intake processes in under five minutes — all without requiring healthcare providers to alter their current workflows. Within its first year, Coral has generated several million dollars in revenue and aims to quadruple its growth by the end of 2026.

Eli Lilly announced its acquisition of Kelonia Therapeutics, a gene therapy company focused on cancer treatments, for up to $7 billion in cash. This marks the largest purchase of a venture-backed biotech startup in recent years, underscoring confidence in Kelonia’s promising genetic medicine pipeline, including a multiple myeloma treatment showing strong clinical results. Founded just four years ago with $50 million in initial funding, Kelonia has quickly advanced, partnering with Astellas Pharma’s subsidiary to develop immuno-oncology therapies. Its innovative platform offers a faster, simpler alternative to CAR T-cell therapies by reprogramming patients' T-cells internally to fight cancer. The deal includes $3.25 billion upfront and potential milestone payments up to $3.75 billion, surpassing recent high-value acquisitions of similar in vivo therapeutic startups by Lilly and others. This acquisition highlights a growing trend in the biotech sector valuing rapid innovation in gene and cell therapy development.

Adidas is set to unveil the Adizero Adios Pro Evo 3, a breakthrough in running shoe design. Despite its robust appearance, this 'super shoe' weighs only 3.4 ounces in a men's size 9—less than half the weight of a typical running shoe. Its remarkably light feel is so surprising that when people receive the box, they often assume it's empty.

Insta360 is introducing the Mic Pro, a new wireless microphone kit featuring transmitters with distinctive round E Ink color screens on the front. Unlike its first AirTag-sized mics introduced in June, the Mic Pro is designed to stand out, allowing users to personalize the screen with images, logos, or artwork. Revealed at the 2026 NAB Show in Las Vegas, the Mic Pro boasts a three-microphone array and aims for a global launch later this year, though exact dates remain undisclosed.

Earlier this month, Anthropic revealed it developed an AI system named Mythos Preview, which it chose not to release publicly out of caution. The company claims this AI can detect and exploit software weaknesses, raising alarms about potential dangers to economies, public safety, and national security. However, some experts question the actual extent of Mythos' abilities. Ian Sample speaks with Guardian AI reporter Aisha Down to explore what Anthropic's cautious approach indicates about its broader tactics and whether this move might prompt tighter industry oversight.

Your front desk often represents the first point of contact for patients, guests, and visitors alike—available 24/7 to handle appointment rescheduling, visitor check-ins, or inquiries. Yet, traditional receptionists face limits in managing simultaneous demands, risking missed calls and lost revenue opportunities.

Enter the AI receptionist: a sophisticated system driven by conversational AI and deep integrations with business platforms. These AI agents handle comprehensive front desk tasks smoothly—from booking and rescheduling appointments to greeting visitors, scanning documents, and even managing access control and services like coffee ordering.

AI receptionists come in two main types: voice-first systems that answer calls and manage scheduling round the clock without hold times, and digital human avatars stationed in lobbies or kiosks that interact face-to-face with in-person visitors.

They significantly reduce costs (by 40–60%), decrease no-show rates by 30%, and speed up visitor check-in processes by up to five times. Healthcare settings, office buildings, and hotels benefit immensely, with AI receptionists managing patient registrations, visitor flows, room bookings, and guest services efficiently.

Integrations with APIs allow these AI systems to control physical access, coordinate with HR directories, trigger security protocols, and even handle catering orders, effectively becoming the nerve center of the front-of-house operations.

Implementation is straightforward and swift, typically completed in weeks, involving discovery, system integration, persona customization, and rigorous testing. Continuous monitoring ensures ongoing improvement.

Businesses investing in AI receptionists today gain enhanced availability, scalability, and operational consistency that human-only front desks can't match.

In a detailed conversation on the Me, Myself, and AI podcast, Peter Koerte, Siemens’ managing board member and chief strategy and technology officer, sheds light on how industrial AI is transforming the infrastructure that underpins daily life. Unlike consumer AI, industrial AI emphasizes near-perfect accuracy and works intimately with specialized domain data to enhance factories, transportation systems, energy grids, and buildings. Koerte explains Siemens’ role in optimizing these vital systems, citing examples like forecasting train door malfunctions well in advance and cutting building energy consumption by 30%. They also discuss the critical role of domain expertise, the challenges of proprietary data sharing, and the significant workflow changes industrial AI brings, including the use of smart glasses to empower workers. Collaboration with tech leaders like Nvidia aims to accelerate simulations and chip design, highlighting the broad impact of AI-driven innovation in industry.

This innovative therapy harnesses mRNA technology to deliver personalized cancer treatment tailored to each patient's unique profile.